US senators take hard look at how user fees are structured
This article was originally published in Clinica
Executive Summary
Senators drafting a reauthorisation of the FDA's device user fee programme are looking at ways of keeping fees from rising too quickly while still ensuring sufficient funding for the agency, key staff said at the Medical Device Manufacturers Association (MDMA) annual meeting in Washington, on June 14.